BACK TO TOP
KSE100
168,893.08
4266.79
(2.59%)
KSE100PR
52,969.96
1323.95
(2.56%)
ALLSHR
100,888.78
1889.56
(1.91%)
KSE30
51,723.30
1380.77
(2.74%)
KMI30
236,793.14
7778.72
(3.40%)
BKTI
49,503.80
475.26
(0.97%)
OGTI
32,753.54
643.60
(2.00%)
KMIALLSHR
64,642.44
1584.53
(2.51%)
PSXDIV20
76,937.65
1598.49
(2.12%)
UPP9
59,450.00
1680.08
(2.91%)
NITPGI
44,132.34
1100.41
(2.56%)
NBPPGI
48,136.38
1159.39
(2.47%)
MZNPI
29,417.16
1119.90
(3.96%)
JSMFI
44,159.67
1780.72
(4.20%)
ACI
23,090.01
872.88
(3.93%)
JSGBKTI
70,861.94
1000.73
(1.43%)
HBLTTI
18,052.96
25-02-2026
3.46
(0.02%)
MII30
21,585.40
722.52
(3.46%)
Otsuka Pakistan Limited
PHARMACEUTICALS
Rs.401.51
36.50
(10.00%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Thu, Feb 26, 2026 1:38 PM
REG
DFC
CSF
ODL
Open
401.51
High
401.51
Low
390.00
Volume
137,936
CIRCUIT BREAKER
328.51 — 401.51
DAY RANGE
390.00 — 401.51
52-WEEK RANGE ^
155.62 — 478.89
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
365.01
VAR
21.00
HAIRCUT
27.50
P/E Ratio (TTM) **
18.17
1-Year Change * ^
105.17%
YTD Change * ^
18.70%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Otsuka Pakistan Limited was incorporated in Pakistan as a public limited company. The Company is engaged in the manufacturing, marketing, and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods, and medical equipment. The company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan

KEY PEOPLE
Moin Ur RehmanCEO
Mikio BandoChairperson
Shahab Khalid SubzwariCompany Secretary
ADDRESS

30 - B, Sindhi Muslim Co-Operative, Housing Society, Karachi

WEBSITE

www.otsuka.pk

REGISTRAR

THK Associates (Private) Limited, Plot No. 32-C, Jami Commercial Street 2, D.H.A, Phase-VII, Karachi

AUDITOR

M/s. Yousuf Adil Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
4,858,271.00
Shares
12,100,000
Free Float
3,025,000
Free Float
25.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Feb 26, 2026Financial results for the Quarter ended Dec 31, 2025 View   PDF
Oct 30, 2025Transmission of Quarterly Report for the Period Ended September 30, 2025 View   PDF
Oct 28, 2025Financial Results for the quarter ended September 30, 2025 View   PDF
Oct 10, 2025Transmission of Annual Report for the Year Ended June 30, 2025 View   PDF
Aug 27, 2025Financial Results for the Year Ended June 30, 2025 View   PDF
DateTitleDocument
Feb 16, 2026Board Meeting View   PDF
Oct 14, 2025Board of Directors Meeting View   PDF
Oct 3, 2025Notice of 37th Annual General Meeting View   PDF
Aug 13, 2025Board of Directors Meeting View   PDF
Apr 14, 2025Board of Directors Meeting View   PDF
DateTitleDocument
Jan 6, 2026Change of Company Secretary View   PDF
Jan 5, 2026Disclosure of Material Information View   PDF
Dec 12, 2025Annual maintenance (closure of production) View   PDF
Oct 28, 2025EXTRACTS FROM THE RESOLUTIONS PASSED IN 37TH AGM OF THE COMPANY View   PDF
Oct 22, 2025Corporate Briefing Session 2025 View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales3,779,5183,163,8683,035,0852,851,733
Profit after Taxation27,677(4,763)(7,207)231,797
EPS2.29(0.39)(0.60)19.16
Q1 2026Q3 2025Q2 2025Q1 2025
Sales1,076,104884,757972,790810,914
Profit after Taxation120,07912,590166,538(119,685)
EPS9.921.0413.76(9.89)
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)22.8418.2421.2232.49
Net Profit Margin (%)0.73(0.15)(0.24)8.13
EPS Growth (%)687.1835.00(103.13)(39.99)
PEG0.19(8.58)1.17(0.32)

Payouts

Financial Reports